Tag: ADK.V

A.I. Chris' Corner Health Science Medical Devices Series Technology

Diagnos (ADK.V) analysis – Chris’ Corner

12 November 2021
Staff

Today Equity.Guru founder, Chris Parry, speaks with Stefan Quenneville, Director of Life Sciences and Biotech Research…

A.I. Technology

Diagnos (ADK.V) places well in artificial intelligence competition and prepares for CARA rollout

29 October 2021
Staff

Diagnos (ADK.V) announced that their artificial intelligence program delivered world-class results in the GAMMA (Glaucoma GrAding…

A.I. Biotech Featured Content Golzadeh Health Science Scribes Series Technology Video

To Invest or Not: Diagnos (ADK.V)

3 September 2021
Staff

In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission…

A.I. Health Science Roundtable Series Technology Today's Analysis Video

Diagnos (ADK.V) – Investor Roundtable

3 September 2021
Staff

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a…

A.I. Morton Scribes Technology

Diagnos (ADK.V) latest agreement with IRIS the Vision Group aims to help Canadians see better

10 June 2021
Staff

Diagnos (ADK.V) inked a multi-year agreement with IRIS The Visual Group 1990 to launch an artificial…

A.I. Eyewear/Optical Health Science Robertson Scribes Technology

DIAGNOS (ADK.V) Enters Exclusive Distribution Agreement

6 April 2021
Staff

DIAGNOS (ADK.V) has signed an exclusive distribution agreement with Diagnos Europe. “Our goal is to launch…